2012, Number 2
<< Back
Arch Med Urg Mex 2012; 4 (2)
Tranexamic acid for the treatment of significant heat injury: an international, randomized, double-blind, placebo-controlled study (Multicenter study CRASH 3)
Loría CJ
Language: Spanish
References: 5
Page: 87-88
PDF size: 36.80 Kb.
Text Extraction
No abstract
REFERENCES
Shakur H et al. The CRASH-3 trial (world maternal antifibrinolytic trial): tranexamic acid for the treatment of postpartum haemorrhage: An international randomized, double blind placebo controlled trial. Trials 2010; 11: 40.
Roberts I et al. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2011; (1): CD004896.
World Health Organization, United Nations Children’s Fund, United Nations Population Fund, World Bank. Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA, and The World Bank. 2007: Geneva.
Shakur H et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010; 376(9734): 23-32.
Roberts I et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet 2011; 377(9771): 1096-101, 1101 e1-2.
Full text